Fluticasone/Formoterol Breath Actuated Inhaler
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Fluticasone/Formoterol Breath Actuated Inhaler, covering 2018-10-23 to 2018-10-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Effect of Fluticasone/Formoterol Breath Actuated Inhaler (BAI) or Relvar® Ellipta® DPI on Ventilation Heterogeneity in Asthma [Phase 3]